| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Drug Abuse > Alcohol and Drug Rehab: Substance Abuse and Mental Health Issues |
|
Advice Pool - Alcohol and Drug Rehab: Substance Abuse and Mental Health Issues
According to the National Institute of Mental Health, depression is the most com According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product mon diagnosis among adults in the United States today. It is estimated that one ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ut of three depressed people suffer from some form of addiction or substance abu lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e problem. In addition to the above, there appears to be a common tendency among here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe those suffering from depression to abuse drugs or alcohol as a means of coping w d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro th their symptoms. Many of these people end up with an addiction to those substa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ces. Dual diagnosis can create a very complex situation for both the profession easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi al, as well as, the individual. One of the obstacles they face is while the pers nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n may feel depressed, there are many drugs, including alcohol that create sympto and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s similar in nature to depression. The "million dollar" question is, which came ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi irst, the depressive disorder or the addiction/alcoholism causing it? Although ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a here appears to be a clear link between depression and addiction or drug/alcohol dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod use, it is not clear that one necessarily precedes the other. Many times though, cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin the depressive disorder appears first and the person begins to use drugs or alco tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen hol as a means to better cope with the symptoms. This type of self-medication ge t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel erally leads to addiction or alcoholism with the person in need of drug rehab or ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust alcoholism treatment. Regardless of which issue develops first, they must be tre y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ted co-currently in rehab for the person to fully recover. The most important t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ing is to work with a physician who fully understands drug addiction, alcoholism elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip and is associated with an accredited addiction treatment center tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Buy Telecom Equipments For Small Businesses Become Prepared for an Emergency 95% of Retirees Retire Into Poverty!
|